✦ LIBER ✦

Tenofovir disoproxil fumarate: Role in hepatitis B treatment

✍ Scribed by Stephen N. Wong; Anna S.F. Lok

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 85 KB
Volume: 44
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.21307

No coin nor oath required. For personal study only.

✦ Synopsis

a Median (range). Results presented separately for HBeAg-positive b and HBeAg-negative c patients. Abbreviations: LAM, lamivudine; ADV, adefovir; TDF, tenofovir; PCR, polymerase chain reaction-based assay (lower limit of detection ϭ 2-3 log 10 copies/mL).

📜 SIMILAR VOLUMES

Anti-hepatitis B virus efficacy of tenof

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

✍ Yves Benhamou; Herve Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

for the TECOVIR Study Group Tenofovir disoproxil fumarate (TDF) has shown in vitro activity against both HIV and hepatitis B virus (HBV). We retrospectively evaluated the efficacy of TDF (300 mg/d), administered as a part of anti-retroviral therapy, in a large cohort of HIV/HBV-coinfected patients.

Tenofovir disoproxil fumarate (TDF), emt

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

✍ Yun-Fan Liaw; I-Shyan Sheen; Chuan-Mo Lee; Ulus Salih Akarca; George V. Papatheo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Data are limited on the safety and effectiveness of oral antivirals other than lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B (CHB) in patients with decompensated liver disease. This Phase 2, double-blind study randomized 112 patients with CHB and decompensated liver disease

Tenofovir in chronic hepatitis B

✍ P. Del Poggio; C. Jamoletti; M. Zaccanelli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

We have read with interest the article of Dr. Fartoux and colleagues, 1 who assessed the factors involved in the progression of fibrosis in 135 mild chronic hepatitis C (CHC) patients who underwent paired liver biopsies after a median of 61 months. Steatosis was the only determinant of fibrosis prog

Comparison of adefovir and tenofovir in

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

✍ Florian van Bömmel; Thomas Wünsche; Stefan Mauss; Petra Reinke; Alexandra Bergk; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudineresistant hepatitis B virus (HBV) infection. Tenofovir disoproxil fumarate, a congender of adefovir that is used in the treatment of HIV infected patients, has recently been shown to also be effective in patients w

The rtA194T polymerase mutation impacts

The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus strains

✍ Samad Amini-Bavil-Olyaee; Ulf Herbers; Julie Sheldon; Tom Luedde; Christian Trau 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

Tenofovir is a new effective treatment option for patients with chronic hepatitis B, but could be potentially hampered by mutations in the hepatitis B virus (HBV) polymerase conferring drug resistance. Drug resistance may occur preferentially if long-term administration is required, for example, in

Potential role for Interleukin-28B genot

Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

✍ Jason Grebely; Kathy Petoumenos; Margaret Hellard; Gail V. Matthews; Vijayapraka 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Polymorphisms in the IL28B (interleukin-28B) gene region are important in predicting outcome following therapy for chronic hepatitis C virus (HCV) infection. We evaluated the role of IL28B in spontaneous and treatment-induced clearance following recent HCV infection. The Australian Trial in Acute He